Before I even got through the door, they said, "It's AstraZeneca today. Is that okay?"
Then they wrote it on my card, along with the batch number.
Advertisement
by The Free Joy State » Mon Apr 12, 2021 11:36 pm
by CoraSpia » Tue Apr 13, 2021 12:27 am
The Free Joy State wrote:The Black Forrest wrote:
Indeed. I asked when I got my first shot and they said it was pfizer. They even wrote that on my vaccine card.
Before I even got through the door, they said, "It's AstraZeneca today. Is that okay?"
Then they wrote it on my card, along with the batch number.
by Shazbotdom » Tue Apr 13, 2021 12:43 am
The Free Joy State wrote:The Black Forrest wrote:
Indeed. I asked when I got my first shot and they said it was pfizer. They even wrote that on my vaccine card.
Before I even got through the door, they said, "It's AstraZeneca today. Is that okay?"
Then they wrote it on my card, along with the batch number.
NCAAF Record Estimates
LSU Tigers: 9-3
Tulane Green Wave: 10-2
NHL Playoffs
East: FLA 4 - 0 CAR
West: DAL 2 - 4 VGK
Trump is Part of the Swamp...(VoteGold2024)
1 x NFL Picks League Champion (2021)
ShazWeb || IIWiki || Imperial Space Adminisration || Disc: ShazbertBot#0741
by Kowani » Tue Apr 13, 2021 1:32 am
Abolitionism in the North has leagued itself with Radical Democracy, and so the Slave Power was forced to ally itself with the Money Power; that is the great fact of the age.
by New Visayan Islands » Tue Apr 13, 2021 2:13 am
by Ethel mermania » Tue Apr 13, 2021 3:46 am
CoraSpia wrote:The Alma Mater wrote:
You can usually also make an educated guess. Do you live in the middle of nowhere far from facilities with cold storage ? Then you probably will not get pfizer from your "local" doctor.
Tbh though, even though it'd be a logistical nightmare to give everyone a choice on which vaccine they get nobody should have to make an 'educated guess' as to what it is. You should have a right to know what's going into your own body, and to make your decision to accept or refuse that.
by Shanghai industrial complex » Tue Apr 13, 2021 5:02 am
Sharania wrote:Bulgarian PM: price of Pfizer vaccine jumps from €12 to €19,50The European Commission has signed contracts with Pfizer for the supply of COVID-19 vaccines in 2022 and 2023 for €19.50 per dose, Bulgarian Prime Minister Boyko Borissov revealed on Sunday.
Borissov boasted how European solidarity and his diplomatic efforts had secured an additional 2.7 million doses of the Pfizer vaccine to be delivered to Bulgaria in the next two months.
“Pfizer was €12, then it became €15.50. Contracts are now being signed for 900 million vaccines at a price of €19.50,” the PM said, to illustrate his claim that prices are rising sharply.
“Now we are most afraid of the French variant. So many more variants will appear … Because €19.50 for 900 million will cost nearly €18 billion. First with a jab, then a second, third and fourth,” Borissov continued, adding that experts must set much higher budgets for vaccines in the upcoming budget.
Under an agreement with the vaccine producing companies, the European Commission has so far refused to reveal the price of vaccines. However, last December Belgian Secretary of State Eva De Bleeker shared on Twitter the vaccine prices negotiated by the Commission, as well as the number of doses purchased by her government. Then, it became known that the AstraZeneca jab costs €1.78 compared to €12 for Pfizer-BioNTech.
Borissov is known for often revealing in public, following EU summits, information that should normally be kept confidential. Regarding Bulgaria’s vaccine strategy, EURACTIV reported back in January that the country had put all its eggs in one basket, by banking on the cheaper AstraZeneca vaccine, and not using its quotas of Pfizer-BioNTech and Moderna. Later, Borissov demanded a “fairer distribution”.
First of all - Borissov is clearly a security risk for the EU, what with his murky dealings with Russia and China. Second - yeah, IMAGINE THAT, Pfizer might cost more than AZ - but it works! I mean, does PM Borissov and the likes of him want to "cheapen" the lives of their citizens and opt for something like Sinovac and end up both spending money AND failing to save lives? “Fairer distribution”, my ass... Why Bulgaria won't try it together with the command economy? OH, WAIT...
In other EU news:
More awkward news from Germany: German Chancellor Angela Merkel suddenly canceled her appointment for vaccination with the AstraZeneca vaccine, which was scheduled for April 11. Merkel was to be vaccinated at Berlin's Tempelhofer Feld Vaccination Center. According to the news, the appointment was canceled through Doctolib, an online appointment service.
At the same time, government spokesman Steffen Seibert said that the chancellor will be vaccinated "as soon as possible" and will inform the public about it.
by Borderlands of Rojava » Tue Apr 13, 2021 5:08 am
by Kowani » Tue Apr 13, 2021 9:00 am
Federal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination. All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition. Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.
“We are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement. “Right now, these adverse events appear to be extremely rare.”
While the move was framed as a recommendation to health practitioners in the states, the federal government is expected to pause administration of the vaccine at all federally run vaccination sites. Federal officials expect that state health officials will take that as a strong signal to do the same. Within two hours of the announcement, Gov. Mike DeWine of Ohio, a Republican, advised all health providers in his state to temporarily stop giving Johnson & Johnson shots. New York, Connecticut, Nebraska and other states quickly followed suit.
Scientists with the F.D.A. and C.D.C. will jointly examine possible links between the vaccine and the disorder and determine whether the F.D.A. should continue to authorize use of the vaccine for all adults or limit the authorization. An emergency meeting of the C.D.C.’s outside advisory committee has been scheduled for Wednesday.
The move could complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy. Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That concern has driven up some resistance to all vaccines, even though the AstraZeneca version has not been authorized for emergency use in the United States.
The vast majority of the nation’s vaccine supply comes from two other manufacturers, Pfizer-BioNTech and Moderna, which together deliver more than 23 million doses a week of their two-shot vaccines. There have been no significant safety concerns about either of those vaccines.
But while shipments of the Johnson & Johnson vaccine have been much more limited, the Biden administration had still been counting on using hundreds of thousands of doses every week. In addition to requiring only a single dose, the vaccine is easier to ship and store than the other two, which must be stored at extremely low temperatures. Mark D. Levine, a New York City councilman, lamented on Twitter that the pause would be a “huge setback” for the city’s vaccination program, which he said relies “entirely on J & J” to inoculate the homebound, reach small private doctors’ offices and supply mobile vaccination vans.
“NYC now has the biggest messaging challenge yet in vaccination,” he wrote. “We have to do everything possible to avoid a collapse in confidence in vaccination overall.”
Jeffrey D. Zients, the White House Covid-19 response coordinator, said Tuesday the pause “will not have a significant impact” the Biden administration’s plans to deliver enough vaccine to be able to inoculate all 260 million adults in the United States by the end of May. With the Johnson & Johnson setback, federal officials expect there will only be enough to cover fewer than 230 million adults. But a certain percentage of the population is expected to refuse shots, so the supply may cover all the demand.
Mr. Zients said the administration will still “reach every adult who wants to be vaccinated” by the May 31 target.
Federal officials are concerned that doctors may not be trained to look for the rare disorder if recipients of the vaccine develop symptoms of it. The federal health agencies said Tuesday morning that “treatment of this specific type of blood clot is different from the treatment that might typically be administered” for blood clots.
“Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given,” the statement said.
In a news release, Johnson & Johnson said: “We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines. At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine.” Janssen is the name of Johnson & Johnson’s division that developed the vaccine.
In the United States alone, 300,000 to 600,000 people a year develop blood clots, according to C.D.C. data. But the particular blood clotting disorder that the vaccine recipients developed, known as cerebral venous sinus thrombosis, is extremely rare.
All of the women developed the condition within about two weeks of vaccination, and government experts are concerned that an immune system response triggered by the vaccine was the cause. Federal officials said there was broad agreement in the senior ranks of the administration about the need to pause use of the vaccine while the cases are investigated.
The decision is a fresh blow to Johnson & Johnson. Late last month, the company discovered that workers at a Baltimore plant run by its subcontractor had accidentally contaminated a batch of vaccine, forcing the firm to throw out the equivalent of 13 million to 15 million doses. That plant was supposed to take over supply of the vaccine to the United States from Johnson & Johnson’s Dutch plants, which were certified by federal regulators earlier this year.
The Baltimore plant’s certification by the F.D.A. has now been delayed while inspectors investigate quality control issues, sharply reducing the supply of Johnson & Johnson vaccine. The sudden drop in available doses led to widespread complaints from governors and state health officials who had been expecting much bigger shipments of Johnson & Johnson’s vaccine this week than they got.
States have been using the vaccine in a broad range of settings, including at mass vaccination sites and on college campuses. The vaccine’s one-shot approach has proved popular, and officials have directed it to transient, rural and isolated communities where following up with a second dose is more complicated.
It is common for regulators to investigate “safety signals” in new vaccines and other medical products. Very often, the signals prove not to be of concern. But the concerns about Johnson & Johnson’s vaccine mirror concerns about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.
Out of 34 million people who received the vaccine in Britain, the European Union and three other countries, 222 experienced blood clots that were linked with a low level of platelets. The majority of these cases occurred within the first 14 days following vaccination, mostly in women under 60 years of age.
On April 7, the European Medicines Agency, the main regulatory agency, concluded that the disorder was a very rare side effect of the vaccine. Researchers in Germany and Norway published studies on April 9 suggesting that in very rare cases, the AstraZeneca vaccine caused people to make antibodies that activated their own platelets.
Nevertheless, the regulators argued, the benefit of the vaccine — keeping people from being infected with the coronavirus or keeping those few who get Covid-19 out of the hospital — vastly outweighed that small risk. Countries in Europe and elsewhere continued to give the vaccine to older people, who face a high risk of severe disease and death from Covid-19, while restricting it in younger people.
Both AstraZeneca and Johnson & Johnson use the same platform for their vaccine, a virus known as an adenovirus. On Tuesday, the Australian government announced it would not purchase Johnson & Johnson vaccines. They cited Johnson & Johnson’s use of an adenovirus. But there is no obvious reason adenovirus-based vaccines in particular would cause rare blood clots associated with low platelet levels.
AstraZeneca has not yet applied for an emergency use authorization in the United States.
Abolitionism in the North has leagued itself with Radical Democracy, and so the Slave Power was forced to ally itself with the Money Power; that is the great fact of the age.
by Loeje » Tue Apr 13, 2021 9:08 am
Kowani wrote:screamin' into the void
UG Government calls for a "pause" on the Johnson and Johnson vaccineFederal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination. All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition. Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.
“We are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement. “Right now, these adverse events appear to be extremely rare.”
While the move was framed as a recommendation to health practitioners in the states, the federal government is expected to pause administration of the vaccine at all federally run vaccination sites. Federal officials expect that state health officials will take that as a strong signal to do the same. Within two hours of the announcement, Gov. Mike DeWine of Ohio, a Republican, advised all health providers in his state to temporarily stop giving Johnson & Johnson shots. New York, Connecticut, Nebraska and other states quickly followed suit.
Scientists with the F.D.A. and C.D.C. will jointly examine possible links between the vaccine and the disorder and determine whether the F.D.A. should continue to authorize use of the vaccine for all adults or limit the authorization. An emergency meeting of the C.D.C.’s outside advisory committee has been scheduled for Wednesday.
The move could complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy. Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That concern has driven up some resistance to all vaccines, even though the AstraZeneca version has not been authorized for emergency use in the United States.
The vast majority of the nation’s vaccine supply comes from two other manufacturers, Pfizer-BioNTech and Moderna, which together deliver more than 23 million doses a week of their two-shot vaccines. There have been no significant safety concerns about either of those vaccines.
But while shipments of the Johnson & Johnson vaccine have been much more limited, the Biden administration had still been counting on using hundreds of thousands of doses every week. In addition to requiring only a single dose, the vaccine is easier to ship and store than the other two, which must be stored at extremely low temperatures. Mark D. Levine, a New York City councilman, lamented on Twitter that the pause would be a “huge setback” for the city’s vaccination program, which he said relies “entirely on J & J” to inoculate the homebound, reach small private doctors’ offices and supply mobile vaccination vans.
“NYC now has the biggest messaging challenge yet in vaccination,” he wrote. “We have to do everything possible to avoid a collapse in confidence in vaccination overall.”
Jeffrey D. Zients, the White House Covid-19 response coordinator, said Tuesday the pause “will not have a significant impact” the Biden administration’s plans to deliver enough vaccine to be able to inoculate all 260 million adults in the United States by the end of May. With the Johnson & Johnson setback, federal officials expect there will only be enough to cover fewer than 230 million adults. But a certain percentage of the population is expected to refuse shots, so the supply may cover all the demand.
Mr. Zients said the administration will still “reach every adult who wants to be vaccinated” by the May 31 target.
Federal officials are concerned that doctors may not be trained to look for the rare disorder if recipients of the vaccine develop symptoms of it. The federal health agencies said Tuesday morning that “treatment of this specific type of blood clot is different from the treatment that might typically be administered” for blood clots.
“Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given,” the statement said.
In a news release, Johnson & Johnson said: “We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines. At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine.” Janssen is the name of Johnson & Johnson’s division that developed the vaccine.
In the United States alone, 300,000 to 600,000 people a year develop blood clots, according to C.D.C. data. But the particular blood clotting disorder that the vaccine recipients developed, known as cerebral venous sinus thrombosis, is extremely rare.
All of the women developed the condition within about two weeks of vaccination, and government experts are concerned that an immune system response triggered by the vaccine was the cause. Federal officials said there was broad agreement in the senior ranks of the administration about the need to pause use of the vaccine while the cases are investigated.
The decision is a fresh blow to Johnson & Johnson. Late last month, the company discovered that workers at a Baltimore plant run by its subcontractor had accidentally contaminated a batch of vaccine, forcing the firm to throw out the equivalent of 13 million to 15 million doses. That plant was supposed to take over supply of the vaccine to the United States from Johnson & Johnson’s Dutch plants, which were certified by federal regulators earlier this year.
The Baltimore plant’s certification by the F.D.A. has now been delayed while inspectors investigate quality control issues, sharply reducing the supply of Johnson & Johnson vaccine. The sudden drop in available doses led to widespread complaints from governors and state health officials who had been expecting much bigger shipments of Johnson & Johnson’s vaccine this week than they got.
States have been using the vaccine in a broad range of settings, including at mass vaccination sites and on college campuses. The vaccine’s one-shot approach has proved popular, and officials have directed it to transient, rural and isolated communities where following up with a second dose is more complicated.
It is common for regulators to investigate “safety signals” in new vaccines and other medical products. Very often, the signals prove not to be of concern. But the concerns about Johnson & Johnson’s vaccine mirror concerns about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.
Out of 34 million people who received the vaccine in Britain, the European Union and three other countries, 222 experienced blood clots that were linked with a low level of platelets. The majority of these cases occurred within the first 14 days following vaccination, mostly in women under 60 years of age.
On April 7, the European Medicines Agency, the main regulatory agency, concluded that the disorder was a very rare side effect of the vaccine. Researchers in Germany and Norway published studies on April 9 suggesting that in very rare cases, the AstraZeneca vaccine caused people to make antibodies that activated their own platelets.
Nevertheless, the regulators argued, the benefit of the vaccine — keeping people from being infected with the coronavirus or keeping those few who get Covid-19 out of the hospital — vastly outweighed that small risk. Countries in Europe and elsewhere continued to give the vaccine to older people, who face a high risk of severe disease and death from Covid-19, while restricting it in younger people.
Both AstraZeneca and Johnson & Johnson use the same platform for their vaccine, a virus known as an adenovirus. On Tuesday, the Australian government announced it would not purchase Johnson & Johnson vaccines. They cited Johnson & Johnson’s use of an adenovirus. But there is no obvious reason adenovirus-based vaccines in particular would cause rare blood clots associated with low platelet levels.
AstraZeneca has not yet applied for an emergency use authorization in the United States.
by Stellar Colonies » Tue Apr 13, 2021 10:26 am
by The Black Forrest » Tue Apr 13, 2021 10:31 am
Borderlands of Rojava wrote:https://www.clickondetroit.com/news/local/2021/04/12/cdc-michigans-response-to-rising-covid-cases-should-be-to-shut-things-down/
So instead of sending vaccines to the place being hit hardest by the virus, you're suggesting we lock down again, something I doubt anyone here would even comply with? You're suggesting we go through the hell we went through last spring, except worse because we have all the anti lockdown crazies mixed in with everyone else who just doesn't feel like forgoing seeing friends and family for 3 months? It sure feels great being slapped in the face like this. And to think the only reason I voted for Joseph Biden was to help my state escape covid.
by The Black Forrest » Tue Apr 13, 2021 10:33 am
by Stellar Colonies » Tue Apr 13, 2021 10:33 am
by Borderlands of Rojava » Tue Apr 13, 2021 10:39 am
by Borderlands of Rojava » Tue Apr 13, 2021 10:40 am
The Black Forrest wrote:Borderlands of Rojava wrote:https://www.clickondetroit.com/news/local/2021/04/12/cdc-michigans-response-to-rising-covid-cases-should-be-to-shut-things-down/
So instead of sending vaccines to the place being hit hardest by the virus, you're suggesting we lock down again, something I doubt anyone here would even comply with? You're suggesting we go through the hell we went through last spring, except worse because we have all the anti lockdown crazies mixed in with everyone else who just doesn't feel like forgoing seeing friends and family for 3 months? It sure feels great being slapped in the face like this. And to think the only reason I voted for Joseph Biden was to help my state escape covid.
She explained it. Why is it wrong for shutting down for a 2 weeks to a month?
The vaccines won’t stop what is happening as they take a couple weeks.
by The Black Forrest » Tue Apr 13, 2021 11:06 am
Borderlands of Rojava wrote:The Black Forrest wrote:
She explained it. Why is it wrong for shutting down for a 2 weeks to a month?
The vaccines won’t stop what is happening as they take a couple weeks.
Stopping things In a couple weeks is better than not stopping them at all. And considering the covid fatigue going around and the former president fanning the flames, we REALLY cannot afford another 2020 style lockdown.
We need the vaccines more than a place with few cases. When a house is on fire, you don't spray water on all houses equally.
by Stellar Colonies » Tue Apr 13, 2021 11:07 am
Borderlands of Rojava wrote:
Government: We need to do our best to stop covid misinformation from propagating.
Also government:
by Borderlands of Rojava » Tue Apr 13, 2021 11:12 am
by Stellar Colonies » Tue Apr 13, 2021 12:05 pm
Borderlands of Rojava wrote:Stellar Colonies wrote:I'm already seeing the covid vaccine skeptics and assorted conspiracy theorists going slightly nuts over this on sites like Twitter and Reddit.
I dont think this is some illuminati shit but it sure looks like it to the weirdos online. The pentagon didn't do themselves a favor with this.
by Nanatsu no Tsuki » Tue Apr 13, 2021 12:46 pm
Slava Ukraini
Also: THERNSY!!
Your story isn't over;֍Help save transgender people's lives֍Help for feral cats
Cat with internet access||Supposedly heartless, & a d*ck.||Is maith an t-earra an tsíocháin.||No TGsRIP: Dyakovo & Ashmoria
by Galloism » Tue Apr 13, 2021 1:28 pm
by Kannap » Tue Apr 13, 2021 1:57 pm
Users browsing this forum: Eahland, Ethel mermania, Galloism, Heavenly Assault, Kashimura, Kubra, Neo-American States, New Kvenland, Pizza Friday Forever91, San Marlindo, Senscaria, The Acolyte Confederacy, Valentine Z
